Getting Your Ultrasound Right

Schwannomas are frequently mistaken for simple cysts on ultrasound. Both can appear dark (hypoechoic) and both can produce a bright shadow behind them — a feature called posterior acoustic enhancement. A technologist who is not looking specifically for nerve sheath tumors will often call it a cyst and stop there. This is one of the most common imaging misses in schwannomatosis.

Knowing what to ask — before and during the scan — changes what gets documented and reported to your physician.

The most important point: a true simple cyst has zero internal echoes. If any are present — even faint — it is not a simple cyst. Posterior acoustic enhancement occurs in both. Do not let that feature alone be used to call something a cyst.

Key questions to ask during the scan:

• “Have you imaged nerve sheath tumors or schwannomas before?”— If they haven’t, ask them to flag all findings for radiologist review with this specific question.
• “Can you use color Doppler on that mass?” — Schwannomas have internal blood supply. Simple cysts do not. This is the fastest differentiator.
• “Can you tell whether it appears to arise from a nerve?” — The nerve entering or exiting the mass is the defining feature of a nerve sheath tumor. Ask them to look for a tail sign or entering nerve sign.
• “Are there any internal echoes at all — even faint ones?” — Ask them to look again with this specific question. Even subtle echoes rule out a simple cyst.
• “What is the shape — round, or elongated?” — Cysts tend to be round. Schwannomas are often fusiform or oval, following the nerve course.

Getting Your MRI Right

MRI is the primary imaging tool for schwannomatosis. It is the only scan that reliably detects small nerve sheath tumors, shows contrast enhancement, and distinguishes schwannomas from cysts, lipomas, and other soft tissue masses. But a standard MRI ordered without specific instructions will frequently miss small tumors, skip the sequences that matter most for SWN, and produce a report that says “unremarkable” even when tumors are present.

The sequence protocol, the magnet strength, the slice thickness, and what you tell the radiologist before the scan all determine what gets found.

Two different tools for two different questions

Most SWN patients who are followed regularly by an NF neurologist receive a surveillance MRI— a full-body or full-spine scan designed to map all tumors, track size over time, and detect new masses. This is typically ordered without gadolinium contrast and at standard slice thickness (5–6mm). That is not an error. It is the right tool for the question it is answering: how many tumors are there, where are they, and has anything grown?

For that question, breadth matters more than depth. A whole-body MRI at 3mm slices throughout would take three to four hours. Standard thickness covers the whole body in 45–90 minutes and is sensitive enough to detect masses of meaningful size. Contrast is not added to routine surveillance because it extends an already long scan, adds IV placement and gadolinium exposure, and for stable known schwannomas, whether they enhance does not change what the team does next.

The protocol becomes the wrong tool when the clinical question changes.If a mass is new, growing faster than expected, behaving differently, causing a different quality of pain, or is being considered for surgery — the surveillance scan cannot answer that question. That is when contrast, thinner slices at the site of interest, and a radiologist reading with the right context matter. These are not things a routine surveillance order will include automatically, and your neurologist may not add them unless you name the specific question you are asking about a specific mass.

The gap SWN patients most often fall into: they are being followed appropriately on a surveillance protocol, a specific mass becomes concerning, and the answer everyone is working from is still based on the surveillance images — which were never designed to characterize that mass.

When to ask for a targeted study

Ask your neurologist for a separate targeted MRI — with contrast and thinner slices at the site of interest — when:

• A mass has grown noticeably since the last scan
• Pain at a specific tumor site has changed in character, intensity, or constancy
• A mass is being considered for surgery and the surgical team needs to plan
• A radiologist or other provider has called a mass a cyst and you want that ruling confirmed with enhancement imaging
• You are at an institution unfamiliar with SWN and want the most complete documentation before any procedure

MRI sequences — what each one does

Signs the radiologist should look for

• Target sign— ring of decreased T2 signal at the tumor periphery with a bright center; classic for benign nerve sheath tumors on MRI.
• Fascicular sign— internal ring-like pattern representing nerve fascicles within the mass; differentiates nerve sheath tumors from other soft tissue lesions.
• Nerve of origin— the radiologist should identify which nerve the tumor arises from. If this is absent from the report, the mass was not assessed as a nerve sheath tumor.
• Tail sign— nerve fiber entering or exiting the mass; same sign as in ultrasound, visible on MRI as a “tail” of nerve tissue at one or both poles.
• Enhancement pattern— benign schwannomas enhance uniformly and brightly. Heterogeneous, peripheral, or rim enhancement warrants follow-up; it can indicate degeneration or early malignant change.
• Size and number with measurements— baseline measurements are essential for future comparison. If tumors are not individually measured, ask for an addendum.

CT scan

CT is not the primary tool for nerve sheath tumors — it resolves soft tissue poorly and will miss most schwannomas unless they are large. CT has a limited but specific role for SWN patients:

• Preoperative planning when surgery involves bony structures (spine, skull base, pelvis)
• Chest / abdomen / pelvis survey to check for large internal masses not yet imaged by MRI
• CT myelography (contrast injected into the spinal canal) if MRI is contraindicated due to a pacemaker or severe claustrophobia
• Foraminal widening or bony remodeling that hints at a slow-growing intraspinal nerve sheath tumor — visible on CT even when soft tissue is not

PET / FDG-PET

FDG-PET is not part of routine SWN surveillance. It is ordered when malignant transformation to MPNST (malignant peripheral nerve sheath tumor) is suspected.

• When to request it: A known schwannoma that has grown rapidly over weeks to months; a tumor causing new, severe pain qualitatively different from your baseline; a lesion with heterogeneous enhancement or low ADC on DWI.
• What it shows:Benign schwannomas have low FDG uptake. Significantly elevated uptake at a tumor site is a referral threshold for surgical discussion — it is not a diagnosis of MPNST, but it warrants prompt evaluation at an NF center. Your NF specialist will interpret the result in the context of your clinical picture.
• What to tell the ordering physician:“I have schwannomatosis. I have a tumor at [location] that has changed in [growth / pain character / imaging appearance]. I want to rule out malignant transformation before further watchful waiting.”